Q32 Bio Insider Trades
NASDAQ: QTTBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 4 · $30.00M
- Sales
- 11 · $505.08K
- Shares bought / sold
- 3.75M / 70.34K
- Net activity
- Net buying $29.5 million
Q32 Bio insider activity
Over the last 12 months, Q32 Bio insiders reported 22 transactions on SEC Form 4: 4 open-market purchases and 11 sales. Insiders bought $30.0 million and sold $505,080 worth of stock, for net insider buying of $29.5 million. The largest seller was Morrison Jodie Pope, with $312,377 in reported sales.
The most recent filing shows Kalowski Lee (CFO and President) selling 1,301 shares at $8.32 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put QTTB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
QTTB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Morrison Jodie PopeCEO | Sale | 3,221 | $26.80K | Form 4 |
| Oct 6, 2026 | Violette Shelia M.Chief Scientific Officer | Sale | 917 | $7.63K | Form 4 |
| Oct 6, 2026 | Kalowski LeeCFO and President | Sale | 1,301 | $10.82K | Form 4 |
| Aug 25, 2026 | Violette Shelia M.Chief Scientific Officer | Sale | 2,798 | $46.33K | Form 4 |
| Aug 25, 2026 | Morrison Jodie PopeCEO | Sale | 9,845 | $163.03K | Form 4 |
| Aug 25, 2026 | Kalowski LeeCFO and President | Sale | 3,972 | $65.78K | Form 4 |
| Jul 16, 2026 | Violette Shelia M.Chief Scientific Officer | Award | 37,500 | — | Form 4 |
| Jul 16, 2026 | Kalowski LeeCFO and President | Award | 53,250 | — | Form 4 |
| Jul 16, 2026 | Morrison Jodie PopeCEO | Award | 132,000 | — | Form 4 |
| Jun 30, 2026 | Manke IsaacDirector | Option exercise | 53,521 | $149.86K | Form 4 |
| May 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Buy | 625,000 | $5.00M | Form 4 |
| May 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Buy | 1,250,000 | $10.00M | Form 4 |
| May 28, 2026 | Xu DiyongDirector | Buy | 625,000 | $5.00M | Form 4 |
| May 28, 2026 | Xu DiyongDirector | Buy | 1,250,000 | $10.00M | Form 4 |
| Feb 25, 2026 | Kalowski LeeCFO and President | Sale | 3,995 | $18.04K | Form 4 |
| Feb 25, 2026 | Violette Shelia M.Chief Scientific Officer | Sale | 2,815 | $12.71K | Form 4 |
| Feb 25, 2026 | Morrison Jodie PopeCEO | Sale | 9,896 | $44.67K | Form 4 |
| Feb 24, 2026 | Violette Shelia M.Chief Scientific Officer | Award | 37,500 | — | Form 4 |
| Feb 24, 2026 | Morrison Jodie PopeCEO | Award | 132,000 | — | Form 4 |
| Feb 24, 2026 | Kalowski LeeCFO and President | Award | 53,250 | — | Form 4 |
| Dec 2, 2025 | Kalowski LeeCFO and President | Sale | 9,072 | $31.40K | Form 4 |
| Dec 2, 2025 | Morrison Jodie PopeCEO | Sale | 22,506 | $77.87K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4